Wata Chemicals Ltd

Wata Chemicals Ltd has a debt-to-equity ratio of 1.93, indicating a capital structure that is significantly leveraged. The company's liquidity position is assessed as medium, with a current ratio of 0.72, suggesting that it may face challenges in meeting short-term obligations without relying on external financing. The company's liquidity_fpt metric shows a net cash position that is negative after subtracting total debt, which could limit its flexibility in responding to market volatility or capital needs.

In terms of profitability, Wata Chemicals Ltd reports a return on equity (ROE) of 0.42% and a return on assets (ROA) of 0.14%, both of which are below the industry median for Commodity Chemicals. These metrics suggest that the company is underperforming relative to its peers in terms of generating returns for shareholders and utilizing its asset base efficiently.

The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no material geographic diversification. This lack of diversification increases the company's exposure to regional economic downturns or supply chain disruptions. The absence of disclosed geographic breakdowns in the financial snapshot further limits visibility into potential regional risks or growth opportunities.

Wata Chemicals Ltd's growth trajectory appears modest, with no significant revenue growth reported in the latest financial period. The company's capital expenditures were negative at -1.26 million BDT, indicating a reduction in investment in physical assets. This could signal a strategic shift toward cost optimization or a lack of expansion plans in the near term. The outlook for the current fiscal year does not indicate a material change in revenue direction, and no specific growth drivers are disclosed in the available data.

The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The liquidity risk is driven by the company's high debt load and weak current ratio, which could constrain its ability to fund operations without external financing. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares, and no recent equity issuance or dilutive events are disclosed. The company's financial leverage and liquidity constraints are the primary risk factors, with no significant regulatory or geopolitical risks identified in the available data.

Recent events, including filings and transcripts, are not disclosed in the available data. The company's latest financial report does not include any material events or disclosures that would suggest a significant change in its business strategy or financial position. The absence of recent earnings call transcripts or regulatory filings limits the ability to assess management's outlook or strategic direction.

Revenue grew 14.0% year-over-year to BDT 813.5 million, demonstrating top-line expansion momentum.

Net income increased 12.0% year-over-year, indicating improved profitability despite revenue volatility.

Cash conversion of 15.12% ranks best-in-class among 600 commodity chemical peers.

Capex to revenue ratio of -0.007 is above the 75th percentile, suggesting lower capital intensity.

Dilution risk is assessed as low, providing stability for existing shareholders.

Debt-to-equity ratio of 1.93 is in the bottom quartile, signaling high leverage risk.

Credit risk is flagged as high, indicating potential difficulties in meeting financial obligations.

Net margin of 2.14% is below the 4.17% median for the commodity chemicals cohort.

Return on equity of 0.42% significantly underperforms the 3.61% cohort median.